76 related articles for article (PubMed ID: 6807849)
1. The role of a serum DNA-binding protein (64DP) in the diagnosis of malignant neoplasms.
Mitomi T; Nakasaki H; Tajima T; Ogoshi K; Tsuda M; Katsunuma T
Int Adv Surg Oncol; 1982; 5():245-59. PubMed ID: 6807849
[TBL] [Abstract][Full Text] [Related]
2. Purification, properties and identification of a serum DNA binding protein (64DP) and its microheterogeneity.
Tsuda M; Ohkubo T; Kamiguchi H; Suzuki K; Nakasaki H; Mitomi T; Katsunuma T
Tokai J Exp Clin Med; 1982 Mar; 7(2):201-11. PubMed ID: 6808710
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of a serum DNA binding protein (64-DP) in evaluating malignant diseases.
Nakasaki H; Mitomi T; Tajima T; Ogoshi K; Tsuda M; Katsunuma T
Gan; 1981 Apr; 72(2):280-8. PubMed ID: 6895201
[TBL] [Abstract][Full Text] [Related]
4. A clinical evaluation of serum C3DP levels in individuals with malignant diseases.
Parsons RG; Longmire RL; Hoch SO; Hoch JA
Cancer Res; 1977 Mar; 37(3):692-5. PubMed ID: 837370
[TBL] [Abstract][Full Text] [Related]
5. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Haglund C
Anticancer Res; 2002; 22(4):2311-6. PubMed ID: 12174919
[TBL] [Abstract][Full Text] [Related]
6. Isolation, purification and identification of a serum DNA binding protein which increases in malignant diseases.
Ohkubo T; Tsuda M; Yamamura M; Matsumoto M; Kamiguchi H; Katsunuma T
Tokai J Exp Clin Med; 1982 May; 7(3):331-6. PubMed ID: 6896936
[TBL] [Abstract][Full Text] [Related]
7. Isolation and identification of a human serum fibronectin-like protein elevated during malignant disease.
Parsons RG; Todd HD; Kowal R
Cancer Res; 1979 Nov; 39(11):4341-5. PubMed ID: 115574
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
9. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
10. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of alpha 1-fetoprotein and beta-human chorionic gonadotropin in infancy and childhood.
Schneider DT; Calaminus G; Göbel U
Pediatr Hematol Oncol; 2001; 18(1):11-26. PubMed ID: 11205836
[TBL] [Abstract][Full Text] [Related]
12. Purification of a serum DNA binding protein (64DP) with a molecular weight of 64,000 and its diagnostic significance in malignant diseases.
Katsunuma T; Tsuda M; Kusumi T; Ohkubo T; Mitomi T; Nakasaki H; Tajima T; Yokoyama S; Kamiguchi H; Kobayashi K; Shinoda H
Biochem Biophys Res Commun; 1980 Mar; 93(2):552-7. PubMed ID: 6248045
[No Abstract] [Full Text] [Related]
13. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection.
Marrelli D; Roviello F; De Stefano A; Fotia G; Giliberto C; Garosi L; Pinto E
J Am Coll Surg; 2004 Jan; 198(1):51-8. PubMed ID: 14698311
[TBL] [Abstract][Full Text] [Related]
15. TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patients.
Giai M; Roagna R; Ponzone R; Biglia N; Sgro L; Perona M; Sismondi P
Anticancer Res; 1996; 16(2):875-81. PubMed ID: 8687144
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
[TBL] [Abstract][Full Text] [Related]
17. [An early detection of recurrence using reverse transcriptase-polymerase chain reaction (RT-PCR) and methylation-specific polymerase chain reaction (MSP) from peripheral blood in patients after gastrectomy].
Tani N; Ichikawa D; Ikoma D; Ikoma H; Sai S; Tomita H; Okamoto K; Kikuchi S; Fujiwara H; Ochiai T; Ueda Y; Otsuji E; Hagiwara A; Yamagishi H
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1720-2. PubMed ID: 17212086
[TBL] [Abstract][Full Text] [Related]
18. Detection and prognosis of recurrent gastric cancer--is routine follow-up after gastrectomy worthwhile?
Böhner H; Zimmer T; Hopfenmüller W; Berger G; Buhr HJ
Hepatogastroenterology; 2000; 47(35):1489-94. PubMed ID: 11100384
[TBL] [Abstract][Full Text] [Related]
19. Stromal tumors of the stomach. Review of our experience and reclassification of a series of patients.
Cuberes R; Rivera T; Picardo A; Martínez-Peñalver I; Medina M; Jara A; Alias D; de la Plaza R; Pacheco E; Suárez A
Rev Esp Enferm Dig; 2000 Jan; 92(1):13-26. PubMed ID: 10749594
[TBL] [Abstract][Full Text] [Related]
20. IGF binding protein-3 secreted by the prostate adenocarcinoma cells (PC-3): differential effect on PC-3 and normal prostate cell growth.
Kaicer E; Blat C; Imbenotte J; Troalen F; Cussenot O; Calvo F; Harel L
Growth Regul; 1993 Sep; 3(3):180-9. PubMed ID: 7693099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
